Patents Assigned to OXYMO TECHNOLOGIES INC.
  • Patent number: 11944639
    Abstract: The invention concerns a mixture or a composition, that is preferably therapeutically active by topical administration, comprising: —at least one metal salt, the metal being chosen from molybdenum (Mo), tungsten (V), vanadium (V), gold (Au), a lanthanide, in particular lanthanum; —at least one chelating agent; —at least one source of peroxidative radicals; —at least one buffer agent; and pharmaceutical compositions constituted by or comprising said mixture, the methods for producing same and applications thereof, in particular in a method for the therapeutic treatment of a viral infection, and in particular involving a virus of the Herpesviridae family; or as an anti-inflammatory.
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: April 2, 2024
    Assignee: OXYMO TECHNOLOGIES INC.
    Inventors: Rémi Wilmotte, Frédéric Lorenzo, Denis Olivier Chretien
  • Patent number: 10857179
    Abstract: The invention concerns a mixture or a composition, that is preferably therapeutically active by topical administration, comprising: —at least one metal salt, the metal being chosen from molybdenum (Mo), tungsten (W), vanadium (V), gold (Au), a lanthanide, in particular lanthanum; —at least one chelating agent; —at least one source of peroxidative radicals; —at least one buffer agent; and pharmaceutical compositions constituted by or comprising said mixture, the methods for producing same and applications thereof, in particular in a method for the therapeutic treatment of a viral infection, and in particular involving a virus of the Herpesviridae family; or as an anti-inflammatory.
    Type: Grant
    Filed: March 29, 2017
    Date of Patent: December 8, 2020
    Assignee: OXYMO TECHNOLOGIES INC.
    Inventors: Rémi Wilmotte, Frédéric Lorenzo, Denis Olivier Chretien